BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McDonald RJ, Levine D, Weinreb J, Kanal E, Davenport MS, Ellis JH, Jacobs PM, Lenkinski RE, Maravilla KR, Prince MR, Rowley HA, Tweedle MF, Kressel HY. Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates. Radiology 2018;289:517-34. [PMID: 30204075 DOI: 10.1148/radiol.2018181151] [Cited by in Crossref: 121] [Cited by in F6Publishing: 93] [Article Influence: 30.3] [Reference Citation Analysis]
Number Citing Articles
1 Nguyen KL, Yoshida T, Kathuria-Prakash N, Zaki IH, Varallyay CG, Semple SI, Saouaf R, Rigsby CK, Stoumpos S, Whitehead KK, Griffin LM, Saloner D, Hope MD, Prince MR, Fogel MA, Schiebler ML, Roditi GH, Radjenovic A, Newby DE, Neuwelt EA, Bashir MR, Hu P, Finn JP. Multicenter Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRI. Radiology 2019;293:554-64. [PMID: 31638489 DOI: 10.1148/radiol.2019190477] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 12.0] [Reference Citation Analysis]
2 Lattanzio SM; Department of Biomedical Sciences, University of Padua, Padua, Italy. . AIMS Biophysics 2021;8:198-220. [DOI: 10.3934/biophy.2021015] [Reference Citation Analysis]
3 Ponrartana S, Moore MM, Chan SS, Victoria T, Dillman JR, Chavhan GB. Safety issues related to intravenous contrast agent use in magnetic resonance imaging. Pediatr Radiol 2021;51:736-47. [PMID: 33871726 DOI: 10.1007/s00247-020-04896-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Benzon HT, Maus TP, Kang HR, Provenzano DA, Bhatia A, Diehn F, Nelson A, McCormick ZL, Liu BP, de Andres Ares J, Anitescu M, Blackham K, Bhaskar A, Brill S, Collins J, Gulve A, Hurley RW, Jeon YH, Moon JY, Rauck RL, Rodes M, Lee RK, Shah V, Shanthanna H, van Zundert J, Huntoon M, Rathmell JP, Borges MS, Cohen SP, Greenberger PA. The Use of Contrast Agents in Interventional Pain Procedures: A Multispecialty and Multisociety Practice Advisory on Nephrogenic Systemic Fibrosis, Gadolinium Deposition in the Brain, Encephalopathy After Unintentional Intrathecal Gadolinium Injection, and Hypersensitivity Reactions. Anesth Analg 2021;133:535-52. [PMID: 33755647 DOI: 10.1213/ANE.0000000000005443] [Reference Citation Analysis]
5 Ian Paterson D, White JA, Butler CR, Connelly KA, Guerra PG, Hill MD, James MT, Kirpalani A, Lydell CP, Roifman I, Sarak B, Sterns LD, Verma A, Wan D, Crean AM, Grosse-Wortmann L, Hanneman K, Leipsic J, Manlucu J, Nguyen ET, Sandhu RK, Villemaire C, Wald RM, Windram J; Primary Panel., Secondary Panel. 2021 Update on Safety of Magnetic Resonance Imaging: Joint Statement From Canadian Cardiovascular Society/Canadian Society for Cardiovascular Magnetic Resonance/Canadian Heart Rhythm Society. Can J Cardiol 2021;37:835-47. [PMID: 34154798 DOI: 10.1016/j.cjca.2021.02.012] [Reference Citation Analysis]
6 Le Fur M, Caravan P. 86Y PET imaging. Methods Enzymol 2021;651:313-42. [PMID: 33888208 DOI: 10.1016/bs.mie.2020.12.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Durbhakula S, Cohen SP. Gadolinium use for interventional pain procedures: where we are and where we are heading. Regional Anesthesia & Pain Medicine 2019;44:4-6. [DOI: 10.1136/rapm-2018-100163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Schieda N, van der Pol CB, Walker D, Tsampalieros AK, Maralani PJ, Woo S, Davenport MS. Adverse Events to the Gadolinium-based Contrast Agent Gadoxetic Acid: Systematic Review and Meta-Analysis. Radiology 2020;297:565-72. [DOI: 10.1148/radiol.2020200073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
9 Mallio CA, Rovira À, Parizel PM, Quattrocchi CC. Exposure to gadolinium and neurotoxicity: current status of preclinical and clinical studies. Neuroradiology 2020;62:925-34. [DOI: 10.1007/s00234-020-02434-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
10 Akbas E, Unal F, Yuzbasioglu D. Genotoxic effects of gadobutrol and gadoversetamide active substances used in magnetic resonance imaging in human peripheral lymphocytes in vitro. Drug Chem Toxicol 2022;:1-12. [PMID: 35184618 DOI: 10.1080/01480545.2021.1957913] [Reference Citation Analysis]
11 Park HJ, Jang HY, Kim SY. Reply to: "Non-enhanced magnetic resonance as a surveillance tool for hepatocellular carcinoma: Many unresolved issues". J Hepatol 2020;73:213-4. [PMID: 32223917 DOI: 10.1016/j.jhep.2020.03.004] [Reference Citation Analysis]
12 Penn AI, Medved M, Dialani V, Pisano ED, Cole EB, Brousseau D, Karczmar GS, Gao G, Reich BD, Abe H. Discrimination of benign from malignant breast lesions in dense breasts with model-based analysis of regions-of-interest using directional diffusion-weighted images. BMC Med Imaging 2020;20:61. [PMID: 32517657 DOI: 10.1186/s12880-020-00458-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Huang CJ, Bandettini WP, Danis M. Returning Individual Research Results Regarding Gadolinium Deposition in the Brain Is the Preferable Choice. Am J Bioeth 2019;19:77-8. [PMID: 31544659 DOI: 10.1080/15265161.2019.1572829] [Reference Citation Analysis]
14 Pasumarthi S, Tamir JI, Christensen S, Zaharchuk G, Zhang T, Gong E. A generic deep learning model for reduced gadolinium dose in contrast-enhanced brain MRI. Magn Reson Med 2021;86:1687-700. [PMID: 33914965 DOI: 10.1002/mrm.28808] [Reference Citation Analysis]
15 Davies J, Siebenhandl-Wolff P, Tranquart F, Jones P, Evans P. Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration. Arch Toxicol 2022. [PMID: 34997254 DOI: 10.1007/s00204-021-03189-8] [Reference Citation Analysis]
16 Franklin SL, Voormolen N, Bones IK, Korteweg T, Wasser MNJM, Dankers HG, Cohen D, van Stralen M, Bos C, van Osch MJP. Feasibility of Velocity-Selective Arterial Spin Labeling in Breast Cancer Patients for Noncontrast-Enhanced Perfusion Imaging. J Magn Reson Imaging 2021. [PMID: 34121250 DOI: 10.1002/jmri.27781] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Robert P, Vives V, Grindel AL, Kremer S, Bierry G, Louin G, Ballet S, Corot C. Contrast-to-Dose Relationship of Gadopiclenol, an MRI Macrocyclic Gadolinium-based Contrast Agent, Compared with Gadoterate, Gadobenate, and Gadobutrol in a Rat Brain Tumor Model. Radiology 2020;294:117-26. [PMID: 31660804 DOI: 10.1148/radiol.2019182953] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
18 Tweedle MF. Gadolinium Retention in Human Brain, Bone, and Skin. Radiology 2021;300:570-1. [PMID: 34128728 DOI: 10.1148/radiol.2021210957] [Reference Citation Analysis]
19 Rudnick MR, Wahba IM, Leonberg-Yoo AK, Miskulin D, Litt HI. Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review. Am J Kidney Dis 2021;77:517-28. [PMID: 32861792 DOI: 10.1053/j.ajkd.2020.07.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Kanal E, Patton TJ, Krefting I, Wang C. Nephrogenic Systemic Fibrosis Risk Assessment and Skin Biopsy Quantification in Patients with Renal Disease following Gadobenate Contrast Administration. AJNR Am J Neuroradiol 2020;41:393-9. [PMID: 32115422 DOI: 10.3174/ajnr.A6448] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Iv M, Ng NN, Nair S, Zhang Y, Lavezo J, Cheshier SH, Holdsworth SJ, Moseley ME, Rosenberg J, Grant GA, Yeom KW. Brain Iron Assessment after Ferumoxytol-enhanced MRI in Children and Young Adults with Arteriovenous Malformations: A Case-Control Study. Radiology 2020;297:438-46. [PMID: 32930651 DOI: 10.1148/radiol.2020200378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Chen DYT, Ishii Y, Fan AP, Guo J, Zhao MY, Steinberg GK, Zaharchuk G. Predicting PET Cerebrovascular Reserve with Deep Learning by Using Baseline MRI: A Pilot Investigation of a Drug-Free Brain Stress Test. Radiology 2020;296:627-37. [PMID: 32662761 DOI: 10.1148/radiol.2020192793] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Wang CL, Soloff EV. Contrast Reaction Readiness for Your Department or Facility. Radiol Clin North Am 2020;58:841-50. [PMID: 32792118 DOI: 10.1016/j.rcl.2020.04.002] [Reference Citation Analysis]
24 Gallo E, Diaferia C, Gregorio ED, Morelli G, Gianolio E, Accardo A. Peptide-Based Soft Hydrogels Modified with Gadolinium Complexes as MRI Contrast Agents. Pharmaceuticals (Basel) 2020;13:E19. [PMID: 31973215 DOI: 10.3390/ph13020019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
25 Pirasteh A, Lovrec P, Pedrosa I. Imaging and its Impact on Defining the Oligometastatic State. Semin Radiat Oncol 2021;31:186-99. [PMID: 34090645 DOI: 10.1016/j.semradonc.2021.03.006] [Reference Citation Analysis]
26 Prince MR. A Breakthrough in Gadolinum-based Contrast Agent Hypersensitivity Reactions. Radiology 2020;296:322-3. [DOI: 10.1148/radiol.2020201644] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Dillman JR, Davenport MS. Gadolinium retention - 5 years later…. Pediatr Radiol 2020;50:166-7. [PMID: 31975183 DOI: 10.1007/s00247-019-04540-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Weinreb JC, Rodby RA, Yee J, Wang CL, Fine D, McDonald RJ, Perazella MA, Dillman JR, Davenport MS. Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation. Radiology 2021;298:28-35. [PMID: 33170103 DOI: 10.1148/radiol.2020202903] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
29 Jakobsen JÅ, Quattrocchi CC, Müller FHH, Outteryck O, Alcázar A, Reith W, Fraga P, Panebianco V, Sampedro A, Pietura R. Patterns of use, effectiveness and safety of gadolinium contrast agents: a European prospective cross-sectional multicentre observational study. BMC Med Imaging 2021;21:74. [PMID: 33879075 DOI: 10.1186/s12880-021-00600-9] [Reference Citation Analysis]
30 Daniels SP, Ross AB, Sneag DB, Gardon SN, Li G, Hanna A, Tuite MJ. Intravenous contrast does not improve detection of nerve lesions or active muscle denervation changes in MR neurography of the common peroneal nerve. Skeletal Radiol 2021. [PMID: 34021773 DOI: 10.1007/s00256-021-03812-w] [Reference Citation Analysis]
31 Tweedle MF. Next-Generation MRI Contrast Agents: Still Including Gadolinium. Radiology 2020;294:127-8. [DOI: 10.1148/radiol.2019192113] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
32 Kartamihardja AAP, Ariyani W, Hanaoka H, Taketomi-Takahashi A, Koibuchi N, Tsushima Y. The Role of Ferrous Ion in the Effect of the Gadolinium-Based Contrast Agents (GBCA) on the Purkinje Cells Arborization: An In Vitro Study. Diagnostics (Basel) 2021;11:2310. [PMID: 34943547 DOI: 10.3390/diagnostics11122310] [Reference Citation Analysis]
33 Elezaby M, Lees B, Maturen KE, Barroilhet L, Wisinski KB, Schrager S, Wilke LG, Sadowski E. BRCA Mutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging Considerations. Radiology 2019;291:554-69. [PMID: 31038410 DOI: 10.1148/radiol.2019181814] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
34 Galmiche C, Moal B, Marnat G, Sagnier S, Schweitzer C, Dousset V, Sibon I, Tourdias T. Delayed Gadolinium Leakage in Ocular Structures: A Potential Marker for Age- and Vascular Risk Factor-Related Small Vessel Disease? Invest Radiol 2021;56:425-32. [PMID: 33481460 DOI: 10.1097/RLI.0000000000000757] [Reference Citation Analysis]
35 de Boer A, Harteveld AA, Pieters TT, Blankestijn PJ, Bos C, Froeling M, Joles JA, Verhaar MC, Leiner T, Hoogduin H. Decreased native renal T1 up to one week after gadobutrol administration in healthy volunteers. J Magn Reson Imaging 2020;52:622-31. [PMID: 31799793 DOI: 10.1002/jmri.27014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Furlan C, Montarolo F, Di Gregorio E, Parolisi R, Atlante S, Buffo A, Bertolotto A, Aime S, Gianolio E. Analysis of the Gadolinium retention in the Experimental Autoimmune Encephalomyelitis (EAE) murine model of Multiple Sclerosis. J Trace Elem Med Biol 2021;68:126831. [PMID: 34364067 DOI: 10.1016/j.jtemb.2021.126831] [Reference Citation Analysis]
37 Lunyera J, Mohottige D, Alexopoulos AS, Campbell H, Cameron CB, Sagalla N, Amrhein TJ, Crowley MJ, Dietch JR, Gordon AM, Kosinski AS, Cantrell S, Williams JW Jr, Gierisch JM, Ear B, Goldstein KM. Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents: A Systematic Review. Ann Intern Med 2020;173:110-9. [PMID: 32568573 DOI: 10.7326/M20-0299] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
38 Woolen SA, Troost JP, Khalatbari S, Pujara AC, McDonald JS, McDonald RJ, Shankar P, Lewin AA, Melsaether AN, Westphal SM, Patterson KH, Nettles A, Welby JP, Patel PP, Kiros N, Piccoli L, Davenport MS. Prospective multicenter assessment of patient preferences for properties of gadolinium-based contrast media and their potential socioeconomic impact in a screening breast MRI setting. Eur Radiol 2021. [PMID: 34047845 DOI: 10.1007/s00330-021-07982-y] [Reference Citation Analysis]
39 Nguyen KL, Hu P, Finn JP. Cardiac Magnetic Resonance Quantification of Structure-Function Relationships in Heart Failure. Heart Fail Clin 2021;17:9-24. [PMID: 33220890 DOI: 10.1016/j.hfc.2020.08.001] [Reference Citation Analysis]
40 Palmer OR, Braybrooks GG, Cao AA, Diaz JA, Greve JM. Collateral vein dynamics in mouse models of venous thrombosis: Pathways consistent with humans. Thrombosis Research 2019;182:116-23. [DOI: 10.1016/j.thromres.2019.08.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 Kartamihardja AAP, Kumasaka S, Hilfi L, Kameo S, Koyama H, Tsushima Y. Biosorption of different gadolinium (Gd) complexes from water by Eichhornia crassipes (water hyacinth). Int J Phytoremediation 2021;:1-9. [PMID: 34613832 DOI: 10.1080/15226514.2021.1984388] [Reference Citation Analysis]
42 Thomas MA, Hazany S, Ellingson BM, Hu P, Nguyen KL. Pathophysiology, classification, and MRI parallels in microvascular disease of the heart and brain. Microcirculation 2020;27:e12648. [PMID: 32640064 DOI: 10.1111/micc.12648] [Reference Citation Analysis]
43 Rezk T, Fontana M, Gillmore JD. A review of the criteria for non-invasive diagnosis of cardiac transthyretin amyloidosis. Expert Opinion on Orphan Drugs 2021;9:87-94. [DOI: 10.1080/21678707.2021.1898371] [Reference Citation Analysis]
44 Schieda N, Maralani PJ, Hurrell C, Tsampalieros AK, Hiremath S. Updated Clinical Practice Guideline on Use of Gadolinium-Based Contrast Agents in Kidney Disease Issued by the Canadian Association of Radiologists. Can Assoc Radiol J 2019;70:226-32. [DOI: 10.1016/j.carj.2019.04.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
45 Chacko L, Martone R, Cappelli F, Fontana M. Cardiac Amyloidosis: Updates in Imaging. Curr Cardiol Rep 2019;21:108. [PMID: 31375984 DOI: 10.1007/s11886-019-1180-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
46 Torresan MF, Wolosiuk A. Critical Aspects on the Chemical Stability of NaYF 4 -Based Upconverting Nanoparticles for Biomedical Applications. ACS Appl Bio Mater 2021;4:1191-210. [DOI: 10.1021/acsabm.0c01562] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
47 Colbert CM, Le AH, Shao J, Currier JW, Ajijola OA, Hu P, Nguyen KL. Ferumoxytol-enhanced magnetic resonance T1 reactivity for depiction of myocardial hypoperfusion. NMR Biomed 2021;34:e4518. [PMID: 33830561 DOI: 10.1002/nbm.4518] [Reference Citation Analysis]
48 Bennani-Baiti B, Krug B, Giese D, Hellmich M, Bartsch S, Helbich TH, Baltzer PAT. Evaluation of 3.0-T MRI Brain Signal after Exposure to Gadoterate Meglumine in Women with High Breast Cancer Risk and Screening Breast MRI. Radiology 2019;293:523-30. [PMID: 31638488 DOI: 10.1148/radiol.2019190847] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
49 Duncan BR, Hasegawa M, Marshall DA, Gonzalez-Cuyar LF, Paulsen M, Kobayashi M, Maravilla KR, Simpson CD. Variability in hair gadolinium concentrations among decedents who received gadolinium-based contrast agents. Anal Bioanal Chem 2021;413:1571-82. [PMID: 33506336 DOI: 10.1007/s00216-020-03116-3] [Reference Citation Analysis]
50 Qiu T, Lan Y, Gao W, Zhou M, Liu S, Huang W, Zeng S, Pathak JL, Yang B, Zhang J. Photoacoustic imaging as a highly efficient and precise imaging strategy for the evaluation of brain diseases. Quant Imaging Med Surg 2021;11:2169-86. [PMID: 33936997 DOI: 10.21037/qims-20-845] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Good NM, Lee HD, Hawker ER, Su MZ, Gilad AA, Martinez-gomez NC. Hyperaccumulation of Gadolinium by Methylorubrum extorquens AM1 Reveals Impacts of Lanthanides on Cellular Processes Beyond Methylotrophy. Front Microbiol 2022;13:820327. [DOI: 10.3389/fmicb.2022.820327] [Reference Citation Analysis]
52 Tear LR, Carrera C, Gianolio E, Aime S. Towards an Improved Design of MRI Contrast Agents: Synthesis and Relaxometric Characterisation of Gd-HPDO3A Analogues. Chemistry 2020;26:6056-63. [PMID: 32133687 DOI: 10.1002/chem.202000479] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
53 Nachtigall LB, Karavitaki N, Kiseljak-Vassiliades K, Ghalib L, Fukuoka H, Syro LV, Kelly D, Fleseriu M. Physicians' awareness of gadolinium retention and MRI timing practices in the longitudinal management of pituitary tumors: a "Pituitary Society" survey. Pituitary 2019;22:37-45. [PMID: 30456434 DOI: 10.1007/s11102-018-0924-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
54 Glide-Hurst CK, Paulson ES, McGee K, Tyagi N, Hu Y, Balter J, Bayouth J. Task group 284 report: magnetic resonance imaging simulation in radiotherapy: considerations for clinical implementation, optimization, and quality assurance. Med Phys 2021;48:e636-70. [PMID: 33386620 DOI: 10.1002/mp.14695] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
55 Kim G, Donohoe K, Smith MP, Hamaguchi R, Johnson AR, Singhal D, Tsai LL. Use of non-contrast MR in diagnosing secondary lymphedema of the upper extremities. Clin Imaging 2021;80:400-5. [PMID: 34534773 DOI: 10.1016/j.clinimag.2021.08.018] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Varlamov EV, Hinojosa-Amaya JM, Fleseriu M. Magnetic resonance imaging in the management of prolactinomas; a review of the evidence. Pituitary 2020;23:16-26. [PMID: 31659622 DOI: 10.1007/s11102-019-01001-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
57 Shah PD, Domchek SM. The contemporary landscape of genetic testing and breast cancer: Emerging issues. Breast J 2020;26:1549-55. [DOI: 10.1111/tbj.13968] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
58 Takanezawa Y, Nakamura R, Kusaka T, Ohshiro Y, Uraguchi S, Kiyono M. Significant contribution of autophagy in mitigating cytotoxicity of gadolinium ions. Biochem Biophys Res Commun 2020;526:206-12. [PMID: 32201079 DOI: 10.1016/j.bbrc.2020.03.080] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Narine R, Osman H, Wongwaisayawan S, Morgan S, Lavallee LT, Schieda N. Unenhanced MRI of the abdomen and pelvis for surveillance of patients with stage 1 testicular cancer post-radical orchiectomy. Abdom Radiol (NY) 2021;46:1157-62. [PMID: 32901295 DOI: 10.1007/s00261-020-02715-z] [Reference Citation Analysis]
60 El Hamrani D, Vives V, Buchholz R, Même W, Factor C, Fingerhut S, Sperling M, Karst U, Robert P, Même S. Effect of Long-Term Retention of Gadolinium on Metabolism of Deep Cerebellar Nuclei After Repeated Injections of Gadodiamide in Rats. Invest Radiol 2020;55:120-8. [PMID: 31876627 DOI: 10.1097/RLI.0000000000000621] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
61 Ringler MD, Rhodes NG, Ayers-Ringler JR, Jakaitis DR, McDonald RJ, Kallmes DF, McDonald JS. Gadolinium retention within multiple rat organs after intra-articular administration of gadolinium-based contrast agents. Skeletal Radiol 2021;50:1419-25. [PMID: 33404669 DOI: 10.1007/s00256-020-03695-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Cho SB, Lee AL, Chang HW, Kim KA, Yoo WJ, Yeom JA, Rho MH, Kim SJ, Lim YJ, Han M. Prospective Multicenter Study of the Safety of Gadoteridol in 6163 Patients. J Magn Reson Imaging 2020;51:861-8. [PMID: 31663202 DOI: 10.1002/jmri.26940] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
63 Ross JS, Buckner Petty SA, Brinjikji W, Hoxworth JM, Lehman VT, Middlebrooks EH, Patel AC, Wood CP. Multiple reader comparison of 2D TOF, 3D TOF, and CEMRA in screening of the carotid bifurcations: Time to reconsider routine contrast use? PLoS One 2020;15:e0237856. [PMID: 32877415 DOI: 10.1371/journal.pone.0237856] [Reference Citation Analysis]
64 Anderson MA, Harrington SG, Kozak BM, Gee MS. Strategies to Reduce the Use of Gadolinium-Based Contrast Agents for Abdominal MRI in Children. American Journal of Roentgenology 2020;214:1054-64. [DOI: 10.2214/ajr.19.22232] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
65 Radbruch A, Richter H, Bücker P, Berlandi J, Schänzer A, Deike-Hofmann K, Kleinschnitz C, Schlemmer HP, Forsting M, Paulus W, Martin LF, van Thriel C, Karst U, Jeibmann A. Is Small Fiber Neuropathy Induced by Gadolinium-Based Contrast Agents? Invest Radiol 2020;55:473-80. [PMID: 32604384 DOI: 10.1097/RLI.0000000000000677] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
66 Weinreb JC, Rodby RA, Yee J, Wang CL, Fine D, McDonald RJ, Perazella MA, Dillman JR, Davenport MS. Use of Intravenous Gadolinium-Based Contrast Media in Patients With Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation. Kidney Med 2021;3:142-50. [PMID: 33604544 DOI: 10.1016/j.xkme.2020.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
67 Cocozza S, Pontillo G, Lanzillo R, Russo C, Petracca M, Di Stasi M, Paolella C, Vola EA, Criscuolo C, Moccia M, Lamberti A, Monti S, Brescia Morra V, Elefante A, Palma G, Tedeschi E, Brunetti A. MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis. Neuroradiology 2019;61:155-62. [DOI: 10.1007/s00234-018-02150-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 8.3] [Reference Citation Analysis]
68 Le Fur M, Rotile NJ, Correcher C, Clavijo Jordan V, Ross AW, Catana C, Caravan P. Yttrium-86 Is a Positron Emitting Surrogate of Gadolinium for Noninvasive Quantification of Whole-Body Distribution of Gadolinium-Based Contrast Agents. Angew Chem Int Ed Engl 2020;59:1474-8. [PMID: 31750991 DOI: 10.1002/anie.201911858] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
69 Gulino P, Bianchi A, Diciotti S, Scionti A, Sali L, Papadopulos P, Mascalchi M. The switch from Gd-DTPA to Gd-DOTA is not associated with decrease of the T1 signal intensity of the pallidus and dentate in a pediatric population. Acta Radiol 2021;62:368-76. [PMID: 32529894 DOI: 10.1177/0284185120927920] [Reference Citation Analysis]
70 Chettle DR, McNeill FE. Elemental analysis in living human subjects using biomedical devices. Physiol Meas 2019;40:12TR01. [PMID: 31816604 DOI: 10.1088/1361-6579/ab6019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
71 Topcuoglu ED, Topcuoglu OM, Semiz Oysu A, Bukte Y. Does Gadoterate Meglumine Cause Gadolinium Retention in the Brain of Children? A Case-Control Study. J Magn Reson Imaging 2020;51:1471-7. [PMID: 31665554 DOI: 10.1002/jmri.26954] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
72 McDonald RJ, Weinreb JC, Davenport MS. Symptoms Associated with Gadolinium Exposure (SAGE): A Suggested Term. Radiology 2021;:211349. [PMID: 34783590 DOI: 10.1148/radiol.2021211349] [Reference Citation Analysis]
73 Shuvaev S, Akam E, Caravan P. Molecular MR Contrast Agents. Invest Radiol 2021;56:20-34. [PMID: 33074931 DOI: 10.1097/RLI.0000000000000731] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
74 O'Donohue LS, Shankar PR, Stein EB, Davenport MS. Characteristics of gadolinium-based contrast media cancellation at the point of care: a 15-month assessment of FDA-inspired medication guides on gadolinium retention. Abdom Radiol (NY) 2021;46:799-804. [PMID: 32812066 DOI: 10.1007/s00261-020-02670-9] [Reference Citation Analysis]
75 Hannoun S, Issa R, El Ayoubi NK, Haddad R, Baalbaki M, Yamout BI, Khoury SJ, Hourani R. Gadoterate Meglumine Administration in Multiple Sclerosis has no Effect on the Dentate Nucleus and the Globus Pallidus Signal Intensities. Acad Radiol 2019;26:e284-91. [PMID: 30527456 DOI: 10.1016/j.acra.2018.11.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
76 Neal CH. Screening Breast MRI and Gadolinium Deposition: Cause for Concern? Journal of Breast Imaging 2022;4:10-8. [DOI: 10.1093/jbi/wbab074] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Kühn I, Maschke H, Großmann A, Hauenstein K, Weber MA, Zettl UK, Storch A, Walter U. Dentate-nucleus gadolinium deposition on magnetic resonance imaging: ultrasonographic and clinical correlates in multiple sclerosis patients. Neurol Sci 2021. [PMID: 34735650 DOI: 10.1007/s10072-021-05702-4] [Reference Citation Analysis]
78 Ontaneda D, Raza PC, Mahajan KR, Arnold DL, Dwyer MG, Gauthier SA, Greve DN, Harrison DM, Henry RG, Li DKB, Mainero C, Moore W, Narayanan S, Oh J, Patel R, Pelletier D, Rauscher A, Rooney WD, Sicotte NL, Tam R, Reich DS, Azevedo CJ; North American Imaging in Multiple Sclerosis Cooperative (NAIMS). Deep grey matter injury in multiple sclerosis: a NAIMS consensus statement. Brain 2021;144:1974-84. [PMID: 33757115 DOI: 10.1093/brain/awab132] [Reference Citation Analysis]
79 Schieda N, Krishna S, Davenport MS. Update on Gadolinium-Based Contrast Agent-Enhanced Imaging in the Genitourinary System. AJR Am J Roentgenol 2019;:1-11. [PMID: 30973785 DOI: 10.2214/AJR.19.21137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
80 Michali-Stolarska M, Tukiendorf A, Zacharzewska-Gondek A, Jacków-Nowicka J, Chrzanowska J, Trybek G, Bladowska J. MRI Protocol for Pituitary Assessment in Children with Growth or Puberty Disorders-Is Gadolinium Contrast Administration Actually Needed? J Clin Med 2021;10:4598. [PMID: 34640616 DOI: 10.3390/jcm10194598] [Reference Citation Analysis]
81 Jacobs KG, Chan FP, Cheng JY, Vasanawala SS, Maskatia SA. 4D flow vs. 2D cardiac MRI for the evaluation of pulmonary regurgitation and ventricular volume in repaired tetralogy of Fallot: a retrospective case control study. Int J Cardiovasc Imaging 2020;36:657-69. [PMID: 31894524 DOI: 10.1007/s10554-019-01751-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
82 van der Molen AJ. Gadolinium Deposition in the Brain and Body. Journal of the Belgian Society of Radiology 2019;103:71. [DOI: 10.5334/jbsr.1945] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 McDonald JS, McDonald RJ. MR Imaging Safety Considerations of Gadolinium-Based Contrast Agents: Gadolinium Retention and Nephrogenic Systemic Fibrosis. Magn Reson Imaging Clin N Am 2020;28:497-507. [PMID: 33040991 DOI: 10.1016/j.mric.2020.06.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
84 Le Fur M, Caravan P. The biological fate of gadolinium-based MRI contrast agents: a call to action for bioinorganic chemists. Metallomics 2019;11:240-54. [PMID: 30516229 DOI: 10.1039/c8mt00302e] [Cited by in Crossref: 55] [Cited by in F6Publishing: 17] [Article Influence: 27.5] [Reference Citation Analysis]
85 Mahmood F, Nielsen UG, Jørgensen CB, Brink C, Thomsen HS, Hansen RH. Safety of gadolinium based contrast agents in magnetic resonance imaging-guided radiotherapy – An investigation of chelate stability using relaxometry. Physics and Imaging in Radiation Oncology 2022;21:96-100. [DOI: 10.1016/j.phro.2022.02.015] [Reference Citation Analysis]
86 Cox J, Graham Y. Gadolinium use and risks: an update for colleagues in primary care. Br J Gen Pract 2021;71:444-5. [PMID: 34593391 DOI: 10.3399/bjgp21X717125] [Reference Citation Analysis]
87 Lancelot E, Desché P. Gadolinium Retention as a Safety Signal: Experience of a Manufacturer. Invest Radiol 2020;55:20-4. [PMID: 31725063 DOI: 10.1097/RLI.0000000000000605] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
88 Huneault L, Davenport MS, Verma R, Walker D, Schieda N. Twitter and Gadolinium Retention: Patient-Reported Perceptions of Gadolinium-Based Contrast Agents. J Am Coll Radiol 2020;17:1355-8. [PMID: 32822645 DOI: 10.1016/j.jacr.2020.07.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
89 Caussy C, Johansson L. Magnetic resonance-based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.Endocrinol Diabetes Metab. 2020;3:e00134. [PMID: 33102797 DOI: 10.1002/edm2.134] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
90 Mcdonald RJ, Kallmes DF. Signal Intensity Changes at MRI Following GBCA Exposure: Incidental Finding or Cause for Concern? Radiology 2020;296:131-3. [DOI: 10.1148/radiol.2020201256] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
91 Minaeva O, Hua N, Franz ES, Lupoli N, Mian AZ, Farris CW, Hildebrandt AM, Kiernan PT, Evers LE, Griffin AD, Liu X, Chancellor SE, Babcock KJ, Moncaster JA, Jara H, Alvarez VE, Huber BR, Guermazi A, Latour LL, McKee AC, Soto JA, Anderson SW, Goldstein LE. Nonhomogeneous Gadolinium Retention in the Cerebral Cortex after Intravenous Administration of Gadolinium-based Contrast Agent in Rats and Humans. Radiology 2020;294:377-85. [PMID: 31769744 DOI: 10.1148/radiol.2019190461] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
92 Ackermans N, Taylor C, Tam R, Carruthers R, Kolind S, Kang H, Freedman MS, Li DK, Traboulsee AL. Effect of different doses of gadolinium contrast agent on clinical outcomes in MS. Mult Scler J Exp Transl Clin 2019;5:2055217318823796. [PMID: 30800415 DOI: 10.1177/2055217318823796] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
93 Liu CY, Ramos M, Moreno-Dominguez D, Prčkovska V, Rodrigues P, Blank M, Moser FG, Agris J. Automated workflow for volumetric assessment of signal intensity ratio on T1-weighted MR images after multiple gadolinium administrations. J Med Imaging (Bellingham) 2021;8:014005. [PMID: 33649733 DOI: 10.1117/1.JMI.8.1.014005] [Reference Citation Analysis]
94 Daniels SP, Mankowski Gettle L, Blankenbaker DG, Lee KS, Ross AB. Contrast-enhanced ultrasound-guided musculoskeletal biopsies: our experience and technique. Skeletal Radiol 2021;50:673-81. [PMID: 32935196 DOI: 10.1007/s00256-020-03604-8] [Reference Citation Analysis]
95 Kierans AS, Gavlin A, Wehrli N, Flisnik LM, Eliades S, Pittman ME. Utility of gadolinium for identifying the malignant potential of pancreatic cystic lesions. Abdom Radiol (NY) 2022. [PMID: 35195765 DOI: 10.1007/s00261-022-03446-z] [Reference Citation Analysis]
96 Leiner T. Is gadolinium-enhanced magnetic resonance imaging possible without leaving a trace? J Magn Reson Imaging 2021;53:1293-4. [PMID: 33559382 DOI: 10.1002/jmri.27535] [Reference Citation Analysis]
97 Ge S, Nemiroski A, Mirica KA, Mace CR, Hennek JW, Kumar AA, Whitesides GM. Magnetische Levitation in Chemie, Materialwissenschaft und Biochemie. Angew Chem 2020;132:17962-8011. [DOI: 10.1002/ange.201903391] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
98 Damme NM, Fernandez DP, Wang LM, Wu Q, Kirk RA, Towner RA, McNally JS, Hoffman JM, Morton KA. Analysis of retention of gadolinium by brain, bone, and blood following linear gadolinium-based contrast agent administration in rats with experimental sepsis. Magn Reson Med 2020;83:1930-9. [PMID: 31677194 DOI: 10.1002/mrm.28060] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
99 Ntoulia A, Barnewolt CE, Doria AS, Ho-Fung VM, Lorenz N, Mentzel HJ, Back SJ. Contrast-enhanced ultrasound for musculoskeletal indications in children. Pediatr Radiol 2021. [PMID: 33783575 DOI: 10.1007/s00247-021-04964-6] [Reference Citation Analysis]
100 Liu M. Lifecycle of Gadolinium-Based Contrast Agents. J Magn Reson Imaging 2021;53:1295-9. [PMID: 32989902 DOI: 10.1002/jmri.27374] [Reference Citation Analysis]
101 Shrestha R, Teesdale-Spittle PH, Lewis AR, Rendle PM. Gadolinium Complexes Attached to Poly Ethoxy Ethyl Glycinamide (PEE-G) Dendrons: Magnetic Resonance Imaging Contrast Agents with Increased Relaxivity. Chempluschem 2020;85:1881-92. [PMID: 32845091 DOI: 10.1002/cplu.202000409] [Reference Citation Analysis]
102 Ahmad F, Treanor L, Mcgrath TA, Walker D, Mcinnes MD, Schieda N. Safety of Off‐Label Use of Ferumoxtyol as a Contrast Agent for MRI : A Systematic Review and Meta‐Analysis of Adverse Events. J Magn Reson Imaging 2021;53:840-58. [DOI: 10.1002/jmri.27405] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
103 Denmark D, Ruhoy I, Wittmann B, Ashki H, Koran LM. Altered Plasma Mitochondrial Metabolites in Persistently Symptomatic Individuals after a GBCA-Assisted MRI. Toxics 2022;10:56. [DOI: 10.3390/toxics10020056] [Reference Citation Analysis]
104 Zhang H, Tang X, Lv Y, Hu D, Sun J, Wang Y, Zhou J, Peng Y. Amide Proton Transfer-Weighted (APTw) Imaging of Intracranial Infection in Children: Initial Experience and Comparison with Gadolinium-Enhanced T1-Weighted Imaging. Biomed Res Int 2020;2020:6418343. [PMID: 32509865 DOI: 10.1155/2020/6418343] [Reference Citation Analysis]
105 Vaarwerk B, Mallebranche C, Affinita MC, van der Lee JH, Ferrari A, Chisholm JC, Defachelles AS, De Salvo GL, Corradini N, Minard-Colin V, Morosi C, Brisse HJ, McHugh K, Bisogno G, van Rijn RR, Orbach D, Merks JHM. Is surveillance imaging in pediatric patients treated for localized rhabdomyosarcoma useful? The European experience. Cancer 2020;126:823-31. [PMID: 31750944 DOI: 10.1002/cncr.32603] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
106 McDonald JS, Larson NB, Kolbe AB, Hunt CH, Schmitz JJ, Kallmes DF, McDonald RJ. Acute Reactions to Gadolinium-Based Contrast Agents in a Pediatric Cohort: A Retrospective Study of 16,237 Injections. AJR Am J Roentgenol 2021;216:1363-9. [PMID: 32755216 DOI: 10.2214/AJR.20.23602] [Reference Citation Analysis]
107 Ge S, Nemiroski A, Mirica KA, Mace CR, Hennek JW, Kumar AA, Whitesides GM. Magnetic Levitation in Chemistry, Materials Science, and Biochemistry. Angew Chem Int Ed Engl 2020;59:17810-55. [PMID: 31165560 DOI: 10.1002/anie.201903391] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 13.0] [Reference Citation Analysis]
108 Zeng Y, Li H, Li Z, Luo Q, Zhu H, Gu Z, Zhang H, Gong Q, Luo K. Engineered gadolinium-based nanomaterials as cancer imaging agents. Applied Materials Today 2020;20:100686. [DOI: 10.1016/j.apmt.2020.100686] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
109 Neisius U, El-Rewaidy H, Kucukseymen S, Tsao CW, Mancio J, Nakamori S, Manning WJ, Nezafat R. Texture signatures of native myocardial T1 as novel imaging markers for identification of hypertrophic cardiomyopathy patients without scar. J Magn Reson Imaging 2020;52:906-19. [PMID: 31971296 DOI: 10.1002/jmri.27048] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
110 Schuijf JD, Ambale-Venkatesh B, Kassai Y, Kato Y, Kasuboski L, Ota H, Caruthers SD, Lima JA. Cardiovascular ultrashort echo time to map fibrosis-promises and challenges. Br J Radiol 2019;92:20190465. [PMID: 31356106 DOI: 10.1259/bjr.20190465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
111 Lehmann Urban D, Mohamed M, Ludolph AC, Kassubek J, Rosenbohm A. The value of qualitative muscle MRI in the diagnostic procedures of myopathies: a biopsy-controlled study in 191 patients. Ther Adv Neurol Disord 2021;14:1756286420985256. [PMID: 33737953 DOI: 10.1177/1756286420985256] [Reference Citation Analysis]
112 Leiner T. Deep Learning for Detection of Myocardial Scar Tissue: Goodbye to Gadolinium? Radiology 2019;291:618-9. [PMID: 31039075 DOI: 10.1148/radiol.2019190783] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
113 Li H, Zeng Y, Zhang H, Gu Z, Gong Q, Luo K. Functional gadolinium-based nanoscale systems for cancer theranostics. J Control Release 2021;329:482-512. [PMID: 32898594 DOI: 10.1016/j.jconrel.2020.08.064] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
114 van de Stadt SIW, Huffnagel IC, Turk BR, van der Knaap MS, Engelen M. Imaging in X-Linked Adrenoleukodystrophy. Neuropediatrics 2021;52:252-60. [PMID: 34192790 DOI: 10.1055/s-0041-1730937] [Reference Citation Analysis]
115 Mawi H, Narine R, Schieda N. Adequacy of Unenhanced MRI for Surveillance of Small (Clinical T1a) Solid Renal Masses. AJR Am J Roentgenol 2021;216:960-6. [PMID: 33594909 DOI: 10.2214/AJR.20.23458] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
116 Noda SM, Oztek MA, Stanescu AL, Maloney E, Shaw DWW, Iyer RS. Gadolinium retention: should pediatric radiologists be concerned, and how to frame conversations with families. Pediatr Radiol 2021. [PMID: 33978802 DOI: 10.1007/s00247-021-04973-5] [Reference Citation Analysis]